Credit Suisse’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Hold |
0
| – | -$3 | – | 3789 |
|
|
2022
Q4 | – | Sell |
-3,776
| Closed | -$80K | – | 3861 |
|
|
2022
Q3 | $80K | Buy |
3,776
+34
| +0.9% | +$720 | ﹤0.01% | 3461 |
|
|
2022
Q2 | $90K | Buy |
3,742
+47
| +1% | +$1.13K | ﹤0.01% | 3539 |
|
|
2022
Q1 | $184K | Buy |
3,695
+241
| +7% | +$12K | ﹤0.01% | 3374 |
|
|
2021
Q4 | $241K | Buy |
3,454
+99
| +3% | +$6.91K | ﹤0.01% | 3384 |
|
|
2021
Q3 | $313K | Buy |
3,355
+357
| +12% | +$33.3K | ﹤0.01% | 3240 |
|
|
2021
Q2 | $301K | Sell |
2,998
-2,550
| -46% | -$256K | ﹤0.01% | 3276 |
|
|
2021
Q1 | $518K | Sell |
5,548
-14,631
| -73% | -$1.37M | ﹤0.01% | 2934 |
|
|
2020
Q4 | $1.67M | Sell |
20,179
-3,556
| -15% | -$293K | ﹤0.01% | 2242 |
|
|
2020
Q3 | $2.04M | Buy |
23,735
+23,095
| +3,609% | +$1.98M | ﹤0.01% | 1805 |
|
|
2020
Q2 | $60K | Buy |
+640
| New | +$60K | ﹤0.01% | 3218 |
|
|
2020
Q1 | – | Sell |
-2,453
| Closed | -$102K | – | 3531 |
|
|
2019
Q4 | $102K | Buy |
2,453
+1,780
| +264% | +$74K | ﹤0.01% | 3397 |
|
|
2019
Q3 | $9K | Buy |
673
+241
| +56% | +$3.22K | ﹤0.01% | 3419 |
|
|
2019
Q2 | $15K | Sell |
432
-1,272
| -75% | -$44.2K | ﹤0.01% | 3407 |
|
|
2019
Q1 | $96K | Buy |
1,704
+1,371
| +412% | +$77.2K | ﹤0.01% | 3254 |
|
|
2018
Q4 | $16K | Buy |
+333
| New | +$16K | ﹤0.01% | 3299 |
|
|
2018
Q2 | – | Sell |
-534
| Closed | -$56K | – | 3594 |
|
|
2018
Q1 | $56K | Buy |
+534
| New | +$56K | ﹤0.01% | 3441 |
|
|
2017
Q4 | – | Sell |
-490
| Closed | -$57K | – | 3655 |
|
|
2017
Q3 | $57K | Buy |
+490
| New | +$57K | ﹤0.01% | 3648 |
|
|
2017
Q2 | – | Sell |
-375
| Closed | -$62K | – | 3515 |
|
|
2017
Q1 | $62K | Buy |
+375
| New | +$62K | ﹤0.01% | 3356 |
|